YSB Inc
Company Profile
Business description
YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Group mainly engaged in i) wholesales of pharmaceutical and healthcare products offline or online through its online platform; ii) retail of pharmaceutical and healthcare products through its retail shops; iii) operating online platform that enable the pharmaceutical distributors and vendors to sell their own pharmaceutical and healthcare products using the Group’s online platform; iv) providing SaaS solution to downstream pharmacies to streamline their inventory management; and v) providing medical testing services to primary healthcare institutions. The Group principally operates in the PRC and generates the majority of its revenues from the PRC.
Contact
No. 8 Brand Street, No. 397 Xingang Middle Road
Yaoshibang Building
TIT Creative Industry Zone
Guangzhou
CHNT: +86 4001180958
Sector
Healthcare
Stock type
Defensive
Industry
Pharmaceutical Retailers
Fiscal Year End
31 December 2025
Employees
6,620
Stocks News & Analysis
stocks
Overvalued ASX share as market underestimates downside risks
stocks
New production imminent for undervalued ASX gas play
stocks
Going into earnings, is Tesla stock a buy, a sell, or fairly valued?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,324.60 | 40.80 | 0.44% |
CAC 40 | 8,201.98 | 27.78 | 0.34% |
DAX 40 | 24,226.46 | 395.47 | 1.66% |
Dow JONES (US) | 46,469.36 | 278.75 | 0.60% |
FTSE 100 | 9,405.20 | 50.63 | 0.54% |
HKSE | 25,858.83 | 611.73 | 2.42% |
NASDAQ | 22,915.18 | 235.21 | 1.04% |
Nikkei 225 | 49,185.50 | 1,603.35 | 3.37% |
NZX 50 Index | 13,344.96 | 55.75 | 0.42% |
S&P 500 | 6,715.45 | 51.44 | 0.77% |
S&P/ASX 200 | 9,031.90 | 43.70 | 0.49% |
SSE Composite Index | 3,863.89 | 24.14 | 0.63% |